Site notifications

Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

1074 result(s) found, displaying 251 to 275

  • AusPAR: Ferric carboxymaltose

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ferric carboxymaltose

  • AusPAR: Midodrine hydrochloride

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Midodrine hydrochloride

  • AusPAR: Elasomeran

    Australian Public Assessment Report (AusPAR)
    Spikevax (elasomeran) for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

  • AusPAR: BNT162b2 (mRNA)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for BNT162b2 (mRNA)

  • AusPAR: Trabectedin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Trabectedin

  • AusPAR: Ad26.COV2.S

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ad26.COV2.S

  • AusPAR: Filgotinib maleate

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Filgotinib maleate

  • AusPAR: Baricitinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Baricitinib

  • AusPAR: Durvalumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Durvalumab

  • AusPAR: Follitropin alfa

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Follitropin alfa

  • AusPAR: Mogamulizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Mogamulizumab

  • AusPAR: Olaparib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Olaparib

  • AusPAR: Omalizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Omalizumab

  • AusPAR: Adalimumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Adalimumab

  • AusPAR: Rituximab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Rituximab

Help us improve this page